Cited by 44Virus-based gene therapy researchCRISPR and Genetic EngineeringRNA Interference and Gene Delivery

Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase

Open access
Moldt, Brian, Staunstrup, Nicklas H, Jakobsen, Maria, Yáñez-Muñoz, Rafael J, Mikkelsen, Jacob G·2008·BMC Biotechnology

Abstract

Background: Circular forms of viral genomic DNA are generated during infection of cells with retroviruses like HIV-1. Such circles are unable to replicate and are eventually lost as a result of cell division, lending support to the prevalent notion that episomal retroviral DNA forms are dead-end products of reverse transcription. Results: We demonstrate that circular DNA generated during transduction with HIV-1-based lentiviral vectors can be utilized as substrate for gene insertion directed by nonviral recombinases co-expressed in the target cells. By packaging of lentiviral genomic RNA in integrase-defective lentiviral vectors, harboring an inactive form of the viral integrase, the normal pathway for viral integration is blocked and circular vector DNA accumulates in transduced cells as a result. We find that the amount of DNA circles is increased 4-fold in cells transduced with integration-defective vectors relative to cells treated with integrase-proficient vectors. By transduction of target cells harboring engineered recognition sites for the yeast Flp recombinase with integration-defective lentiviral vectors containing an ATG-deficient hygromycin B selection gene we demonstrate precise integration of lentiviral vector-derived DNA circles in a drug-selective approach. Moreover, it is demonstrated that trans-acting Flp recombinase can be delivered by Flp-encoding transfected plasmid DNA or, alternatively, by co-transduced integrase-defective lentiviral vectors carrying a Flp expression cassette. Conclusion: Our data provide proof-of-principle that nonviral recombinases, like Flp, produced by plasmid DNA or non-integrating lentiviral vectors can gain access to circular viral recombination substrates and facilitate site-directed genomic insertion of such episomal DNA forms. Replacement of the normal viral integration machinery with nonviral mediators of integration represents a new platform for creation of lentiviral vectors with an altered integration profile.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1472-6750-8-60

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Non-viral yeast Flpx9 recombinase produced by NILV can enter circular viral recombination substrates and facilitate site-directed genomic insertion.

    “Another study explained that non-viral yeast Flpx9 recombinase produced by NILV can enter the circular viral recombination substrates and facilitate the site-directed genomic insertion [111].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. Schroder AR Shinn P Chen H Berry C Ecker JR Bushman F HIV-1 integration in the human genome favors active genes and local hotspots Cell 2002 110 521 529 12202041 10.1016/S0092-8674(02)00864-4 · DOI · Paper page
  2. Marshall HM Ronen K Berry C Llano M Sutherland H Saenz D Bickmore W Poeschla E Bushman FD Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting PLoS ONE 2007 2 e1340 18092005 10.1371/journal.pone.0001340 PMC2129110 · DOI · Paper page
  3. Li L Olvera JM Yoder KE Mitchell RS Butler SL Lieber M Martin SL Bushman FD Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection EMBO J 2001 20 2001/06/19 3272 3281 11406603 10.1093/emboj/20.12.3272 PMC150207 · DOI
  4. Farnet CM Haseltine WA Circularization of human immunodeficiency virus type 1 DNA in vitro J Virol 1991 65 1991/12/01 6942 6952 1834863 PMC250802
  5. Apolonia L Waddington SN Fernandes C Ward NJ Bouma G Blundell MP Thrasher AJ Collins MK Philpott NJ Stable gene transfer to muscle using non-integrating lentiviral vectors Mol Ther 2007 15 2007/08/19 1947 1954 17700544 10.1038/sj.mt.6300281 · DOI · Paper page
  6. Nightingale SJ Hollis RP Pepper KA Petersen D Yu XJ Yang C Bahner I Kohn DB Transient gene expression by nonintegrating lentiviral vectors Mol Ther 2006 13 2006/03/25 1121 1132 16556511 10.1016/j.ymthe.2006.01.008 · DOI · Paper page
  7. Yanez-Munoz RJ Balaggan KS MacNeil A Howe SJ Schmidt M Smith AJ Buch P MacLaren RE Anderson PN Barker SE Duran Y Bartholomae C von Kalle C Heckenlively JR Kinnon C Ali RR Thrasher AJ Effective gene therapy with nonintegrating lentiviral vectors Nat Med 2006 12 2006/02/24 348 353 16491086 10.1038/nm1365 · DOI · Paper page
  8. Vargas J Jr. Gusella GL Najfeld V Klotman ME Cara A Novel integrase-defective lentiviral episomal vectors for gene transfer Human gene therapy 2004 15 361 372 15053861 10.1089/104303404322959515 · DOI
  9. Lombardo A Genovese P Beausejour CM Colleoni S Lee YL Kim KA Ando D Urnov FD Galli C Gregory PD Holmes MC Naldini L Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery Nat Biotechnol 2007 25 2007/10/30 1298 1306 17965707 10.1038/nbt1353 · DOI · Paper page
  10. Yant SR Meuse L Chiu W Ivics Z Izsvak Z Kay MA Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system Nat Genet 2000 25 35 41 10802653 10.1038/75568 · DOI
  11. Buchholz F Angrand PO Stewart AF Improved properties of FLP recombinase evolved by cycling mutagenesis Nat Biotechnol 1998 16 1998/07/14 657 662 9661200 10.1038/nbt0798-657 · DOI
  12. Ivics Z Hackett PB Plasterk RH Izsvak Z Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells Cell 1997 91 501 510 9390559 10.1016/S0092-8674(00)80436-5 · DOI
  13. Leavitt AD Robles G Alesandro N Varmus HE Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection J Virol 1996 70 1996/02/01 721 728 8551608 PMC189872
  14. Butler SL Hansen MS Bushman FD A quantitative assay for HIV DNA integration in vivo Nat Med 2001 7 2001/05/01 631 634 11329067 10.1038/87979 · DOI
  15. Thyagarajan B Olivares EC Hollis RP Ginsburg DS Calos MP Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase Mol Cell Biol 2001 21 3926 3934 11359900 10.1128/MCB.21.12.3926-3934.2001 PMC87055 · DOI
  16. Yant SR Park J Huang Y Mikkelsen JG Kay MA Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells Mol Cell Biol 2004 24 9239 9247 15456893 10.1128/MCB.24.20.9239-9247.2004 PMC517896 · DOI
  17. Surosky RT Urabe M Godwin SG McQuiston SA Kurtzman GJ Ozawa K Natsoulis G Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome J Virol 1997 71 1997/10/06 7951 7959 9311886 PMC192153
  18. Riu E Chen ZY Xu H He CY Kay MA Histone Modifications are Associated with the Persistence or Silencing of Vector-mediated Transgene Expression In Vivo Mol Ther 2007 15 2007/04/26 1348 1355 17457320 10.1038/sj.mt.6300177 · DOI

Cited by

Sorted by citations

Authors
Moldt, B., Staunstrup, N. H., Jakobsen, M., Yáñez-Muñoz, R. J., & Mikkelsen, J. G.
Affiliations
Aarhus University (DK)
Corresponding author
Mikkelsen, Jacob G
Venue
BMC Biotechnology
Published
2008-08-09
Volume
8
Issue
1
Pages
60-60
ISSN
1472-6750 (ISSN-L)
OpenAlex
W2115065031
Cited by
44
References
3
Citations by year
2024: 1 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 1
FWCI
4.37
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Royal Holloway Digital Repository (Royal Holloway University of London) (submittedVersion, cc-by)
  • Royal Holloway Digital Repository (Royal Holloway University of London) (submittedVersion)
Funders
  • Aarhus Universitet
  • Kræftens Bekæmpelse
  • Sundhed og Sygdom, Det Frie Forskningsråd
  • University College London
  • École Polytechnique Fédérale de Lausanne
  • Novo Nordisk
  • Novo Nordisk Fonden
  • University of California, San Francisco
  • Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
lentiviral vectors, circular DNA, episomal DNA, Flp recombinase, viral integration, hygromycin B selection, HIV-1
MeSH terms
DNA Nucleotidyltransferases, DNA, Circular, Fungal Proteins, Genetic Vectors, Transfection, Lentivirus, Mutagenesis, Insertional, Genome, Viral

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review